Biovara approves share capital split prior to fund raising

12 June, 2025|

The issued share capital of Biovara has been increased to 8 million ordinary shares.

Related posts

ACF Research publication of independent thematic research note on Lung Cancer Cough market

Biovara adopts ESG policy

Biovara Limited incorporated as a wholly owned subsidiary of Oxilio Limited